osimertinib,gefitinib
astrazeneca
['gefitinib', 'sclc', 'nsclc', 'flaura', 'osimertinib']
dr. shintaro kanda presents results from phase iii again study (jcog1404) of tki alone (at first, gefitinib but revised to osimertinib) vs with chemotherapy in #egfr nsclc at #asco23. different design from flaura2: chemo starts at day 57 and only 3 cycles. 501 pts randomized. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo